Director James D. Forbes buys 5,000 DENTSPLY SIRONA (XRAY) shares in market trade
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
DENTSPLY SIRONA Inc. director James D. Forbes bought 5,000 shares of common stock in an open-market purchase. The shares were acquired at a price of $13.469 per share on 2026-03-03, giving him direct ownership of 5,000 shares following the transaction.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 5,000 shares ($67,345)
Net Buy
1 txn
Insider
Forbes James D
Role
Director
Bought
5,000 shs ($67K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 5,000 | $13.469 | $67K |
Holdings After Transaction:
Common Stock — 5,000 shares (Direct)
Footnotes (1)
FAQ
What insider transaction did DENTSPLY SIRONA (XRAY) disclose?
DENTSPLY SIRONA disclosed that director James D. Forbes bought 5,000 common shares. The open-market purchase occurred at $13.469 per share on March 3, 2026, and increased his directly owned stake to 5,000 shares after the transaction.
Who is the insider involved in the latest XRAY Form 4 filing?
The insider is James D. Forbes, a director of DENTSPLY SIRONA Inc. He reported an open-market purchase of 5,000 common shares at $13.469 per share, resulting in direct ownership of 5,000 shares following the reported transaction.
Was the recent XRAY insider trade a purchase or a sale?
The recent XRAY insider trade was a purchase. The Form 4 identifies transaction code “P” and describes it as an open-market purchase of 5,000 DENTSPLY SIRONA common shares by director James D. Forbes at $13.469 per share.